Live from the NIH registry
Studies recruiting near Pasadena right now
Top 25 of 3,012 recruiting studies, sorted by proximity — each links to its official registry page
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11
Phase 2
Interventional 270 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: American Society of Clinical Oncology
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: National Cancer Institute (NCI)
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Lymphedema, Fibrosis
Phase 2
Interventional 295 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Baylor College of Medicine — Houston, Texas (14.7 mi)
· Sponsor: Westat
Advancing Discussions Using a Video-based Support Tool About End-of-life Care
Traumatic Injury
N/A
Interventional 270 participants sought
The University of Texas Health Science Center at Houston — Houston, Texas (14.7 mi)
· Sponsor: The University of Texas Health Science Center, Houston
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Houston, Texas (14.7 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Consultants of Texas-Bellaire-67493 — Bellaire, Texas (18.8 mi)
· Sponsor: Boehringer Ingelheim
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease
EARLY/Phase 1
Interventional 24 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Human Papillomavirus
N/A
Observational 600 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
Herpes Zoster (HZ), Vascular Dementia
N/A
Observational 375 participants sought
Center for Clinical Studies, LTD. LLP — Webster, Texas (8.5 mi)
· Sponsor: Center for Clinical Studies, Texas
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention
N/A
Interventional 30 participants sought
Children's Nutrition Research Center — Houston, Texas (14.7 mi)
· Sponsor: Baylor College of Medicine
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Houston, Texas (14.7 mi)
· Sponsor: AstraZeneca
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Houston, Texas (14.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
The University of Texas Md Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: BeOne Medicines
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
IDH1 wt Allele, Recurrent Anaplastic Astrocytoma
Phase 1
Interventional 36 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Texas Children's Hospital — Houston, Texas (14.7 mi)
· Sponsor: Nationwide Children's Hospital
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
Airway Complication of Anesthesia
N/A
Observational 10,500 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: University of Turin, Italy
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
Obesity and Type 2 Diabetes
N/A
Interventional 40 participants sought
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine — Houston, Texas (14.7 mi)
· Sponsor: Baylor College of Medicine
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: Erasca, Inc.
Stem Cells for Erectile Dysfunction Post RALP
Erectile Dysfunction, Prostate Cancer
Phase 1, Phase 2
Interventional 40 participants sought
Houston Methodist — Houston, Texas (14.7 mi)
· Sponsor: The Methodist Hospital Research Institute
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Kelsey-Seybold Clinic Main Campus — Houston, Texas (14.7 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Houston — Houston, Texas (14.7 mi)
· Sponsor: RAI Services Company
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 120 participants sought
Accurate Clinical Management LLC — Houston, Texas (14.7 mi)
· Sponsor: Hoffmann-La Roche